Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium + Salmeterol vs Fluticasone/Salmeterol in COPD
NCT00530842Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2007; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00530842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530842.